Goldman Sachs maintained a Neutral rating on Gilead Sciences (NASDAQ: GILD) and raised its price target of $82.00 (from $75.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Trader Talk

Summer Street Affirms Netural Rating on Gilead (GILD); Early Sovoldi Buy-In May Produce Softer ResultsFebruary 5, 2014 9:35 AM Gilead Sciences (GILD) Target Lifted to $101 at Maxim GroupFebruary 5, 2014 9:18 AM Gilead Sciences (GILD) Target Lifted at Needham & Company Post Q4February 5, 2014 6:52 AM Gilead Sciences, Inc. (GILD) Tops Q4 EPS by 5cFebruary 4, 2014 4:08 PM